Skip to content
← Back to this collection

PUBLICATIONS · 38749033

Perioperative Nivolumab in Resectable Lung Cancer.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
N Engl J Med
Publication date
2024 May 16
First author
Cascone T

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    N Engl J Med. 2024 Aug 8;391(6):572-573. doi: 10.1056/NEJMc2407267.
    note
    Source null
    related pmid
    39115072
    relationship
    Comment in
  2. citation
    N Engl J Med. 2024 Aug 8;391(6):573. doi: 10.1056/NEJMc2407267.
    note
    Source null
    related pmid
    39115073
    relationship
    Comment in
  3. citation
    N Engl J Med. 2024 Aug 8;391(6):573-574. doi: 10.1056/NEJMc2407267.
    note
    Source null
    related pmid
    39115074
    relationship
    Comment in

Authors and identifiers

  1. name
    Cascone T
    type
    Author
  2. name
    Awad MM
    type
    Author
  3. name
    Spicer JD
    type
    Author
  4. name
    He J
    type
    Author
  5. name
    Lu S
    type
    Author
  6. name
    Sepesi B
    type
    Author
  7. name
    Tanaka F
    type
    Author
  8. name
    Taube JM
    type
    Author
  9. name
    Cornelissen R
    type
    Author
  10. name
    Havel L
    type
    Author
  11. name
    Karaseva N
    type
    Author
  12. name
    Kuzdzal J
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Cascone T
    type
    Author
  2. name
    Awad MM
    type
    Author
  3. name
    Spicer JD
    type
    Author
  4. name
    He J
    type
    Author
  5. name
    Lu S
    type
    Author
  6. name
    Sepesi B
    type
    Author
  7. name
    Tanaka F
    type
    Author
  8. name
    Taube JM
    type
    Author
  9. name
    Cornelissen R
    type
    Author
  10. name
    Havel L
    type
    Author
  11. name
    Karaseva N
    type
    Author
  12. name
    Kuzdzal J
    type
    Author
bibliography ids
  1. nci-bib-c6d70ab044e51e4607e5f8a8
book metadata
content sha256
e758b241c5d342a09b99d3c74d32136683ef80861091a308fdf48064f145e8f7
document type
citation
dois
  1. 10.1056/NEJMoa2311926
electronic publication date
display
Source null
precision
missing
year
Source null
evidence scope
bibliographic_metadata_only
id
pubmed:38749033
immutable id
pubmed:38749033@e758b241c5d342a09b99d3c74d32136683ef80861091a308fdf48064f145e8f7
journal
abbreviation
N Engl J Med
issn electronic
1533-4406
issn print
0028-4793
issue
19
name
The New England journal of medicine
nlm unique id
0255562
pages
1756-1769
volume
390
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    N Engl J Med. 2024 Aug 8;391(6):572-573. doi: 10.1056/NEJMc2407267.
    note
    Source null
    related pmid
    39115072
    relationship
    Comment in
  2. citation
    N Engl J Med. 2024 Aug 8;391(6):573. doi: 10.1056/NEJMc2407267.
    note
    Source null
    related pmid
    39115073
    relationship
    Comment in
  3. citation
    N Engl J Med. 2024 Aug 8;391(6):573-574. doi: 10.1056/NEJMc2407267.
    note
    Source null
    related pmid
    39115074
    relationship
    Comment in
outcomes validated
false
pmid
38749033
provenance
batch id
6d213eecf21b6b7867cb
provider
NCBI PubMed ESummary
record sha256
4402c6511833edcf1b7753053443c3bcd43b347e5d1ba311b5152c6e87b16d98
response sha256
684f894a21d8f5f78a3bd0acd8ee4215ff94144487c53dab1056650ee8d6751d
retrieved at
2026-09-09T23:48:19.049083+00:00
publication date
display
2024 May 16
precision
day
year
2024
publication types
  1. Journal Article
  2. Randomized Controlled Trial
  3. Clinical Trial, Phase III
  4. Multicenter Study
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/38749033/
title
Perioperative Nivolumab in Resectable Lung Cancer.

Preserved source evidence · Not medical advice